Lipid Metabolic Reprogramming and Epigenetic Co-Dysregulation Across the Central Chondrosarcoma Grade Spectrum: A Multi-Cohort RNA-seq Study
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27125307 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Batuhan Ayhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics and Traumatology, Haymana State Hospital, Haymana, 06860 Ankara, Türkiye. Hauptthemen laut MEDLINE: Chondrosarcoma, Epigenesis, Genetic, Lipid Metabolism, Bone Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Central chondrosarcoma is the second most common primary malignant bone tumour, and grade progression markedly worsens prognosis. The contributions of lipid metabolic reprogramming and epigenetic co-dysregulation to grade progression remain poorly characterised. We integrated a bulk RNA-seq discovery cohort of 53 graded central chondrosarcomas (GSE299759) with a single-cell analysis of eight chondrosarcomas (GSE184118). Because the atypical cartilaginous tumour (ACT) and dedifferentiated groups each comprised only three samples, the Grade 3 versus Grade 2 contrast was pre-specified as the primary comparison. Curated panels of 44 lipid metabolism genes and 50 epigenetic regulators were assessed by differential expression and a correlation-based connectivity ranking, evaluated by permutation testing. In the primary Grade 3 versus Grade 2 comparison, SQLE, ACACA, and FASN were upregulated (FDR < 0.05), indicating a grade-associated increase in de novo lipogenesis. In the exploratory Grade 3 versus ACT comparison, additional lipid genes (HMGCR, LDLRAP1) and the epigenetic regulators EHMT2 and SIRT2 showed altered expression, although the small ACT group limits these estimates. A connectivity ranking highlighted FASN, KMT2C, TET2, SETD5, and KDM5B; permutation testing confirmed this co-expression structure was non-random (p < 0.0001). Single-cell analysis showed FASN, SETD5, and KDM5B are expressed predominantly in malignant cells, whereas KMT2C and TET2 are not, indicating cell-type heterogeneity. De novo lipogenesis upregulation is the most consistent lipid alteration in high-grade central chondrosarcoma, nominating SQLE, ACACA, and FASN as candidates for experimental investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics and Traumatology, Haymana State Hospital, Haymana, 06860 Ankara, Türkiye.
- Department of Bioinformatics, Graduate School of Health Sciences, Hacettepe University, 06100 Ankara, Türkiye.
- Department of Medical Pathology, Faculty of Medicine, Gazi University, 06560 Ankara, Türkiye.
ORCID-Profile: Batuhan Ayhan, Neslihan Dönmez
Zitieren
APA
Ayhan, B., Dönmez, N., & Ayhan, Z. D. (2026). Lipid Metabolic Reprogramming and Epigenetic Co-Dysregulation Across the Central Chondrosarcoma Grade Spectrum: A Multi-Cohort RNA-seq Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27125307
Vancouver
Ayhan B, Dönmez N, Ayhan ZD. Lipid Metabolic Reprogramming and Epigenetic Co-Dysregulation Across the Central Chondrosarcoma Grade Spectrum: A Multi-Cohort RNA-seq Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27125307
BibTeX
@article{Ayhan2026,
author = {Ayhan, Batuhan and Dönmez, Neslihan and Ayhan, Zeliha Deniz},
title = {Lipid Metabolic Reprogramming and Epigenetic Co-Dysregulation Across the Central Chondrosarcoma Grade Spectrum: A Multi-Cohort RNA-seq Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27125307}
}
EUVIMED